| AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity A Di Micco, G Frera, J Lugrin, Y Jamilloux, ET Hsu, A Tardivel, ... Proceedings of the National Academy of Sciences 113 (32), E4671-E4680, 2016 | 129 | 2016 |
| ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stability ED Spear, ET Hsu, L Nie, EP Carpenter, CA Hrycyna, S Michaelis Disease models & mechanisms 11 (7), dmm033670, 2018 | 43 | 2018 |
| a-Factor analogues containing alkyne-and azide-functionalized isoprenoids are efficiently enzymatically processed and retain wild-type bioactivity V Diaz-Rodriguez, ET Hsu, E Ganusova, ER Werst, JM Becker, ... Bioconjugate Chemistry 29 (2), 316-323, 2018 | 15 | 2018 |
| Fluorescent Farnesyl Diphosphate Analogue: A Probe To Validate trans-Prenyltransferase Inhibitors KH Teng, ET Hsu, YH Chang, SW Lin, PH Liang Biochemistry 55 (31), 4366-4374, 2016 | 6 | 2016 |
| A quantitative FRET assay for the upstream cleavage activity of the integral membrane proteases human ZMPSTE24 and yeast Ste24 ET Hsu, JS Vervacke, MD Distefano, CA Hrycyna Protein Lipidation: Methods and Protocols, 279-293, 2019 | 4 | 2019 |
| Biochemical Investigation of Progeroid Disease Associated Mutations in Human ZMPSTE24 ET Hsu Purdue University, 2018 | 2 | 2018 |
| Elucidation of the Substrate Binding Site of the Yeast Zinc Metalloprotease, Ste24 C Theisen, ET Hsu, P Wiley, J Vervacke, M Distefano, C Hrycyna The FASEB Journal 33 (S1), 631.40-631.40, 2019 | | 2019 |
| ZMPSTE24 Missense Mutations that Cause Progeroid Diseases Decrease Prelamin A Cleavage Activity, Protein Stability, or Both ED Spear, ET Hsu, L Nie, EP Carpenter, CA Hrycyna, S Michaelis bioRxiv, 198069, 2017 | | 2017 |
